Track topics on Twitter Track topics that are important to you
Private multi-asset alternative investment firm Bain Capital is reportedly considering options including the potential sale of revenue cycle management (RCM) company Waystar, Bloomberg reports. In 201...
The deal leaves Bain Capital with a minority stake in the company and values Waystar at $2.7 billion.
Waystar, a provider of revenue cycle technology, today announced it has acquired PARO, a financial assistance predictive analytics solution designed for the healthcare industry. As part of the acquisi...
Earlier this year, Bloomberg News reported that Bain Capital was considering a sale of Waystar with Oracle and Visa named as two potential acquirers.
Bain-Capital-backed revenue cycle management company Waystar is acquiring Digitize.AI, an artificial intelligence firm, to enable faster and smarter prior authorizations in healthcare – one of the ...
Waystar, a provider of cloud-based revenue cycle technology has released an industry survey examining today’s state of the patient financial experience. In the first half of 2019, Waystar surveyed 1...
KPMG announced it is integrating social determinants of health (SDoH) data from revenue cycle provider Waystar to KPMG’s Clinical Intelligence (KCI) platform. The integration will harness SDoH data ...
Waystar is the combination of Navicure and ZirMed, the two top-rated providers of revenue cycle technologies. Waystar simplifies and unifies the healthcare revenue cycle with inno...
We have published hundreds of Waystar news stories on BioPortfolio along with dozens of Waystar Clinical Trials and PubMed Articles about Waystar for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Waystar Companies in our database. You can also find out about relevant Waystar Drugs and Medications on this site too.